“showed a trend”

Of quantitative SC-MRI metrics, spinal cord MTR showed a trend toward being lower in RIS vs HCs ( p = 0.06), and there was already evidence of brain atrophy ( p = 0.05).

In a study of 964 STEMI patients ( 7 ), adverse LV remodeling group showed a trend toward longer symptom-onset-to-balloon time than non-LV remodeling group (182 vs. 165 min, p=0.06), which was consistent with the present study (ischemic time ≥3 vs. <3 hours).

The developmental pace of group C4 was significantly slower than that of group A4 (n = 43, P < 0.02) and showed a trend toward being slower than group B4 (n = 35, P < 0.06).

In the ciliary body, CD45 + expression showed a trend toward elevation in EAU mice (0.442% ± 0.910% vs. 0.088% ± 0.023%, p = 0.0600) compared to controls, but this was not statistically significant (Figure 2D ). 3.3 Expression of IL ‐ 17A significantly increased in the retina and ciliary body of EAU mice The expression of IL‐17A, a marker for the activation of the T‐cell subset, Th17, was assessed in the retina, ciliary body, and cornea in EAU and control mice.

However, L-arginine showed a trend for lower levels at ≤ 24 h ( p = 0.060) and 3 days ( p = 0.063).

The interim results of a randomized study comparing protons with TACE in the setting of bridge to transplant showed a trend to improved 2-year LTC (88% vs. 45%, p = 0.06) and PFS (48% vs. 31%, p = 0.06) in favor of protons. 61 The results of other ongoing studies comparing SBRT versus TACE are awaited.

Additionally, CK activity correlated significantly with IBMFRS ( r = 0.803, p = 0.012) and showed a trend towards significant correlation with αSN concentrations ( r = 0.62, p = 0.06, Figure 2b ).

In cases where N = 57 (comparison with the AUT and TTCT tests), T-test results sometimes showed a trend p = ~0.1 when the MW test showed significance or trend for significance p<0.06.

Within-group analysis showed a trend ( p = 0.06), in the VR group, towards a reduction in number of possible/probable anxiety cases at 6 months, and by 12 months, the number of possible/probable anxiety cases was significantly lower ( p = 0.03) than pre-voice rehabilitation.

The level of GHRL, a key appetite-stimulating hormone, showed a trend of increase by 3.90% ( p = 0.06).

No significantly different variable was detected in the OABSS non-flare and flare groups, older patients showed a trend of experiencing an OABSS flare more frequently ( P = 0.06, Additional file 3 : Table S2).

High intratumoral CD8+ TIL were significantly associated with a better DFS in univariate analysis ( p = 0.03), whereas a high p16 INK4a score showed a trend toward better DFS ( p = 0.06).

In univariable analyses, germline variation in GZMB and PDCD1 showed a trend towards associations with OS according to the dominant model (HR 1.811, 95%CI 0.945–3.364, p = 0.060 and HR 2.027, 95%CI 0.998–4.118, p = 0.051, respectively).

In addition, the patients with bacteremia also showed a trend toward higher levels of TNF-α in plasma (median 3.65, IQR 0–7.28) compared with those with no bacteremia (median 0.53, IQR 0–4.51, P = 0.06).

Post hoc analyses indicated that choline supplementation showed a trend ( p = 0.06, Tukey’s multiple comparisons test) in reducing the number of round and amoeboid microglia in the DG of mice with tibial fractures, while there was no difference between the choline supplemented and naïve group at either timepoint.

For obese individuals, oleoylethanolamide showed a trend towards a positive correlation with BMI (P=0.06, rho=0.42) while this relationship was inverse for controls (P=0.07, rho=-0.34).

FAZ area was significantly larger in the T+M group than in controls ( P = 0.01) and showed a trend toward enlargement compared to the T group ( P = 0.06).

after carrageenan treatments in vivo showed a trend for carrageenan-induced activation of CD19 + B cells which did not abate in the second phase of the cross-over study ( p = 0.06), while the carrageenan-induced activation of CD56 + NK cells was suggestive of carryover effects ( p = 0.06).

Calculations, furthermore, showed a trend towards significant differences in ONLS scores and mobility tests (P = 0.06; 0.053).

CCL3 showed a trend towards increased gene expression ( P = 0.06, Figure 5(c) ) and significantly increased protein levels ( Figure 5(d) ) in CC patients compared to controls.

Multivariable analysis demonstrated that IABP use was independently associated with a lower risk of pulmonary edema (OR 0.4; 95% CI 0.2–0.7; P=0.001) and showed a trend toward reduced mortality (OR 0.54; 95% CI 0.29–1.01; P=0.06). 51 Furthermore, a meta-analysis of 22 observational studies involving 4,653 adult cardiogenic shock patients treated with VA-ECMO assessed the effect of concomitant IABP on short-term mortality.

Compared to controls, the naïve group showed a trend to have more smokers (27% vs 50%; p = 0.06).

The maximum duloxetine dose in completers was positively correlated with decline in TESS scores (r = 0.48, p = 0.01) and the final duloxetine dose showed a trend correlation with decline in TESS scores (r = 0.36, p = 0.06).

Similarly, completion of more races in the current season showed a trend to result in fewer DDs for shoulder injuries (Ratio =0.96 [95% CI =0.93–1.00], P =0.06).

Although the p value did not reach the significant level, the low concentration of DOXO (1 uM and 3 μM) showed a trend of concentration-dependent decreasing effect on the Ca-AP-Lag ( p = 0.06, control vs.